UNCOOKED ALERT: Aurinia Pharmaceuticals said to ... - Part 8
Aurinia Pharmaceuticals, the US-listed biotechnology company, has come under the spotlight amid a rekindling of takeover speculation and talk the activist investor arguing for a sale of the business may be gearing up to exert more pressure with a fourth letter seeking a board seat.
This is paywall protected Betaville Intelligence content. You need to purchase a subscription to access this content. Or get in touch with subscription sales at [email protected] to find out about the different subscription packages on offer.
